Keros Therapeutics, Inc.
KROS
$18.10
$1.277.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.68% | 70.06% | 62.86% | 69.09% | 84.33% |
| Total Receivables | 189.39% | 1,218.88% | 989.65% | 308.43% | 114.14% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 74.87% | 96.29% | 3.65% | 5.93% | -5.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.56% | -14.89% | 3.64% | 69.70% | 30.01% |
| Total Current Assets | 30.30% | 69.35% | 64.00% | 69.57% | 81.33% |
|
|
|||||
| Total Current Assets | 30.30% | 69.35% | 64.00% | 69.57% | 81.33% |
| Net Property, Plant & Equipment | -8.94% | 20.94% | 19.10% | 20.65% | 27.14% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -52.27% | -56.96% | -41.42% | 7.38% | 8.97% |
| Total Assets | 28.23% | 66.40% | 61.49% | 66.44% | 77.56% |
|
|
|||||
| Total Accounts Payable | -53.86% | -19.40% | 33.09% | -15.56% | 28.81% |
| Total Accrued Expenses | -31.41% | 49.19% | 41.69% | 18.55% | 85.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.82% | 103.47% | 100.19% | 96.82% | 203.93% |
| Total Finance Division Other Current Liabilities | 1,175.14% | 1,529.83% | 1,523.74% | -37.44% | -18.24% |
| Total Other Current Liabilities | 1,175.14% | 1,529.83% | 1,523.74% | -37.44% | -18.24% |
| Total Current Liabilities | -16.94% | 63.37% | 110.38% | 12.62% | 73.68% |
|
|
|||||
| Total Current Liabilities | -16.94% | 63.37% | 110.38% | 12.62% | 73.68% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.30% | 22.26% | 24.00% | 25.63% | 27.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -15.58% | 47.87% | 74.73% | 17.25% | 52.72% |
|
|
|||||
| Common Stock & APIC | 10.07% | 29.98% | 30.82% | 59.79% | 65.71% |
| Retained Earnings | 12.33% | 4.00% | 0.99% | -49.12% | -53.22% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 32.04% | 67.90% | 60.56% | 72.04% | 80.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.04% | 67.90% | 60.56% | 72.04% | 80.11% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.04% | 67.90% | 60.56% | 72.04% | 80.11% |
|
|
|||||